SK10042003A3 - Použitie látky obsahujúcej Helicobacter pylori - Google Patents

Použitie látky obsahujúcej Helicobacter pylori Download PDF

Info

Publication number
SK10042003A3
SK10042003A3 SK1004-2003A SK10042003A SK10042003A3 SK 10042003 A3 SK10042003 A3 SK 10042003A3 SK 10042003 A SK10042003 A SK 10042003A SK 10042003 A3 SK10042003 A3 SK 10042003A3
Authority
SK
Slovakia
Prior art keywords
binding
helicobacter pylori
oligosaccharide
substance
nac
Prior art date
Application number
SK1004-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Halina Miller-Podraza
Susann Teneberg
Jonas Angstr�M
Karl-Anders Karlsson
Jari Natunen
Original Assignee
Biotie Therapies Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp. filed Critical Biotie Therapies Corp.
Publication of SK10042003A3 publication Critical patent/SK10042003A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SK1004-2003A 2001-01-19 2002-01-18 Použitie látky obsahujúcej Helicobacter pylori SK10042003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010118A FI20010118A (fi) 2001-01-19 2001-01-19 Uudet helicobacter pylori reseptorit ja niiden käyttö
PCT/FI2002/000043 WO2002056893A1 (en) 2001-01-19 2002-01-18 Novel receptors for $i(helicobacter pylori) and use thereof

Publications (1)

Publication Number Publication Date
SK10042003A3 true SK10042003A3 (sk) 2003-11-04

Family

ID=8560066

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1004-2003A SK10042003A3 (sk) 2001-01-19 2002-01-18 Použitie látky obsahujúcej Helicobacter pylori

Country Status (19)

Country Link
US (1) US20040096465A1 (zh)
EP (1) EP1359922A1 (zh)
JP (1) JP2004519459A (zh)
KR (1) KR100886777B1 (zh)
CN (1) CN100455290C (zh)
AU (1) AU2002229792B2 (zh)
CA (1) CA2434350A1 (zh)
CZ (1) CZ20031914A3 (zh)
EE (1) EE200300339A (zh)
FI (1) FI20010118A (zh)
HU (1) HUP0302790A3 (zh)
IL (1) IL156992A0 (zh)
NO (1) NO20033270L (zh)
NZ (1) NZ526906A (zh)
PL (1) PL363617A1 (zh)
RU (1) RU2306140C2 (zh)
SK (1) SK10042003A3 (zh)
WO (1) WO2002056893A1 (zh)
ZA (1) ZA200305155B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20011671A (fi) * 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
US20050220819A1 (en) * 2002-01-18 2005-10-06 Biotie Therapies Oyj Novel binding epitopes for helicobacter pylori and use thereof
DE60327211D1 (de) * 2002-06-28 2009-05-28 Glykos Finland Oy Therapeutische zusammensetzungen zur verwendung bei der prophylaxe oder behandlung von durchfall
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−1、4結合型N−アセチルグルコサミン含有O−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 N−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US8075674B2 (en) 2006-11-30 2011-12-13 Donaldson Company, Inc. Filter apparatus with pulse cleaning and methods for pulse cleaning filters
AU2008324105B2 (en) * 2007-11-08 2014-01-30 Société des Produits Nestlé S.A. Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
ES2551599T3 (es) * 2012-03-19 2015-11-20 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vacunas de polisacárido antígeno-glicolípido conjugado
US20150297714A1 (en) * 2012-10-29 2015-10-22 The Board Of Trustees Of The University Of Arkansas Novel mucosal adjuvants and delivery systems
CN112023037A (zh) * 2020-09-09 2020-12-04 四川大学 一种聚糖在制备对Hp感染的预防和治疗产品中的应用、产品及制备方法
CN112285338B (zh) * 2020-10-20 2023-04-28 四川大学华西医院 一种copd诊断试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−8産生阻害剤
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof

Also Published As

Publication number Publication date
WO2002056893A8 (en) 2003-11-13
FI20010118A (fi) 2002-07-20
CA2434350A1 (en) 2002-07-25
CN100455290C (zh) 2009-01-28
PL363617A1 (en) 2004-11-29
NZ526906A (en) 2005-03-24
CZ20031914A3 (cs) 2004-04-14
KR20040018329A (ko) 2004-03-03
ZA200305155B (en) 2004-07-19
EE200300339A (et) 2003-10-15
RU2306140C2 (ru) 2007-09-20
WO2002056893A1 (en) 2002-07-25
US20040096465A1 (en) 2004-05-20
NO20033270L (no) 2003-09-19
IL156992A0 (en) 2004-02-08
FI20010118A0 (fi) 2001-01-19
NO20033270D0 (no) 2003-07-18
RU2003125370A (ru) 2005-02-10
AU2002229792B2 (en) 2007-08-16
KR100886777B1 (ko) 2009-03-04
HUP0302790A2 (hu) 2003-11-28
JP2004519459A (ja) 2004-07-02
EP1359922A1 (en) 2003-11-12
HUP0302790A3 (en) 2010-01-28
CN1525862A (zh) 2004-09-01

Similar Documents

Publication Publication Date Title
EP2272522B1 (en) Therapeutic compositions for use in prophylaxis or treatment of diarrheas
Gabius et al. Glycosciences: Status & Perspectives
EP1411952B1 (en) Use of at least one glycoinhibitor substance against infectious diseases
RU2306140C2 (ru) НОВЫЕ РЕЦЕПТОРЫ ДЛЯ Helicobacter pylori И ИХ ПРИМЕНЕНИЕ
US20040180850A1 (en) Methods and compositions for treatment of gastric diseases
AU2002229792A1 (en) Novel receptors for Helicobacter pylori and use thereof
RU2283115C2 (ru) Новые вещества, связывающиеся с helicobacter pylori, и их применение
US20060122148A1 (en) High affinity receptors for helicobacter pylori and use thereof
JP2004519459A5 (zh)
US20050220819A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
Miller-Podraza et al. Novel binding epitope for Helicobacter pylori found in neolacto carbohydrate chains: structure and cross-binding properties
WO2004065400A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
Miller-Podraza et al. Helicobacter pylori binding to new glycans based on N-acetyllactosamine
MILLER-PODRAZA et al. Patent 2434350 Summary
Natunen Use of at least one glycoinhibitor substance
Kononov et al. Intermolecular hydrogen bonding pattern in solutions of sialic acid derivatives dramatically influences their properties

Legal Events

Date Code Title Description
FC9A Refused patent application